• Login
• Admin

Allison, Matthew (2024) α-Amidobenzylboronates and β-Ketobenzylboronates as Inhibitors of Plasma Kallikrein. PhD thesis, University of Nottingham.

Preview

PDF (Thesis for reader access - any sensitive & copyright infringing material removed) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Available under Licence Creative Commons Attribution. Download (2MB) | Preview

Abstract

Hereditary angioedema (HAE), a rare genetic disorder, is associated with uncontrolled plasma kallikrein (PKa) enzyme activity leading to often severe bradykinin-induced swelling in subcutaneous and submucosal membranes in various locations of the body.

This thesis describes a series of α-amidobenzylboronates (n=7) as highly potent covalent inhibitors of PKa. These compounds exhibited time-dependent inhibition of PKa, with the most potent compound, 91, showing IC50 = 66 nM at 1 min, 70 pM at 24 hours. Further compound dissociation studies demonstrated no apparent reversibility comparable to D-Phe-Pro-Arg-chloromethyl ketone (PPACK), a known non-selective covalent PKa inhibitor. Comparison with noncovalent matched pair analogues (n=8) supported the notion of covalent inhibition. Biological evaluation of α-amidobenzylboronates against closely related proteases; FXIIa, FXIa, plasmin, thrombin, and trypsin showed at least 1000-fold specificity towards PKa in the case of each evaluated compound, demonstrating the first selective covalent inhibitors of PKa.

β-ketobenzylboronates were also synthesised (n=2) and showed moderate activity in PKa however no evidence of covalent inhibition was demonstrated from analysis of enzyme binding kinetics and subjection to jump dilution. Lack of covalent binding notwithstanding, compound 125b showed moderate noncovalent activity in PKa (IC50 = 39 nM). Furthermore, β ketonitrile compounds (n=2) were explored, with one example, compound 129b, showing apparent covalent inhibition of PKa (IC50 = 223 nM at 1 min, 33 nM at 60 min)

Item Type:	Thesis (University of Nottingham only) (PhD)
Supervisors:	Stocks, Michael Emsley, Jonas
Keywords:	Plasma Kallikrein, Inhibitor, Covalent, Hereditary Angioedema
Subjects:	Q Science > QP Physiology > QP501 Animal biochemistry R Medicine > RL Dermatology
Faculties/Schools:	UK Campuses > Faculty of Science > School of Pharmacy
Related URLs:	URL URL Type https://pubs.acs.org/doi/10.1021/acsmedchemlett.3c00572 Publisher
Item ID:	78452
Depositing User:	Allison, Matthew
Date Deposited:	24 Jul 2024 04:44
Last Modified:	24 Jul 2024 04:44
URI:	https://eprints.nottingham.ac.uk/id/eprint/78452

Actions (Archive Staff Only)

Edit View